Question 1

What is the catalog number for DDX10 CRISPR Knock Out 293T Cell Line (Human)?

Accepted Answer

The catalog number for DDX10 CRISPR Knock Out 293T Cell Line (Human) is 17792141.

Question 2

What sizes are available for DDX10 CRISPR Knock Out 293T Cell Line (Human)?

Accepted Answer

DDX10 CRISPR Knock Out 293T Cell Line (Human) is available in the following size(s): 1x 10^6 Cells / 1.0 mL.

Question 3

Is DDX10 CRISPR Knock Out 293T Cell Line (Human) in stock?

Accepted Answer

DDX10 CRISPR Knock Out 293T Cell Line (Human) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What temperature does this product ship at?

Accepted Answer

Shipping temperature is chosen based on the product’s stability needs, ranging from ambient to dry ice, and is indicated on the product page. Any related shipping fee is shown clearly in your quotation.

Question 5

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 6

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

DDX10 CRISPR Knock Out 293T Cell Line (Human)

Product Specifications

Gene Name

Gene Aliases

Accession Number

Reactivity

Shipping Conditions

Storage Conditions

Frequently Asked Questions

Explore Other Products

CD3e (T-Cell Marker) (C3e/3125R), 0.2mg/mL

Endoglin / CD105 (Angiogenesis Marker) (ENG/3269), CF594 conjugate, 0.1mg/mL

Moesin (MSN/492), CF647 conjugate, 0.1mg/mL

Moesin (MSN/492), CF568 conjugate, 0.1mg/mL

C1QB / Complement C1q B-Chain (C1QB/2961), 0.2mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, 0.1mg/mL